Loading…
Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component‐deficient individuals
Late complement component‐deficient (LCCD) individuals lack plasma bactericidal activity and are highly susceptible to meningococcal disease. Phagocytosis plays a significant role in immune defence against meningococci and involves FcγRIIa (CD32) on leucocytes. Two allotypic forms are currently reco...
Saved in:
Published in: | Clinical and experimental immunology 1998-01, Vol.111 (1), p.97-101 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Late complement component‐deficient (LCCD) individuals lack plasma bactericidal activity and are highly susceptible to meningococcal disease. Phagocytosis plays a significant role in immune defence against meningococci and involves FcγRIIa (CD32) on leucocytes. Two allotypic forms are currently recognized: FcγRIIa‐R131 and RIIa‐H131. Neutrophils with the IIa‐H/H131 allotype are more effective in phagocytosis than IIa‐R/R131. We studied the distributions of IIa‐R131 and IIa‐H131 allotypes among 29 Russian LCCD patients who had suffered from recurrent episodes of meningococcal disease. The distribution of IIa‐R/R131 to heterozygous IIa‐R/H131 to homozygous IIa‐H/H131 genotypes was 0.14:0.29:0.57 for LCCD patients who developed the first episode of disease before 10 years of age. The distribution was 0.21:0.64:0.14 for patients who experienced meningococcal disease above the age of 10 years (χ2 = 6, P |
---|---|
ISSN: | 0009-9104 1365-2249 |
DOI: | 10.1046/j.1365-2249.1998.00484.x |